Future Science Group
Browse

sorry, we can't preview this file

SupplementaryTables.docx (99.49 kB)

Supplementary Tables – The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data

Download (99.49 kB)
dataset
posted on 2022-06-15, 09:06 authored by Taylor & FrancisTaylor & Francis, Satoru Iwasa, Hideaki Bando, Yongzhe Piao, Kenichi Yoshizawa, Kensei Yamaguchi

  

Supplementary Table 1. Overview of targeted therapeutics approved for advanced gastric cancer

  

Supplementary Table 2: Published real-world studies on ramucirumab-containing regimens in AGC


  

Supplementary Table 3. Published clinical studies on ramucirumab-containing regimens in AGC in the first-line setting

  

Supplementary Table 4. Published clinical studies on ramucirumab-containing regimens in AGC in the third-line and perioperative settings

  

Supplementary Table 5. New and ongoing studies on ramucirumab in advanced gastric cancer (NCT and jRCT databases)

Funding

Eli Lilly Japan K.K.

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC